For biosimilars, the most common failure is an assumption that FDA approval of a biosimilar automatically produces rapid market share conversion when, in practice, brand rebate strategies, formulary positioning decisions, and prescriber inertia all intervene
Comparing Results When comparing Saxenda and Ozempic, its important to consider how quickly you want to see results and how long youre willing to take the medication
The same pathway that produces appetite suppression
Pretreatment with GLP-1(2836) reduces myocardial infarct size in mice
Patients trust our clinic for consistent results, compassionate care, and a commitment to safety
Then theres all these other somewhat less regulated I mean, significantly less regulated compounds that are quite easy to obtain